Bivalirudin safer, more effective than heparin for treating heart attack patients undergoing coronary intervention

Close Up Scientist using microscope in laboratory room while making medical testing and research

Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can lower the risk of death or major bleeding by 31 percent.

‘Quordle’ today: Here are the answers and hints for November 7

Previous article

Strategy suggests combining surrogate markers for kidney disease progression in clinical trials

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations